ArticleThe EPMA journal2026

Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity.

Anita Sventekova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.